The patient was implanted with the reactive system on (b)(6) 2023.The patient reported pain around the implantable pulse generator (ipg) pocket.I t was reported (date unknown) that the ipg pocket was injected with lidocaine to help alleviate the pain/discomfort.Reportedly, (date unknown) the patient then developed an infection at the ipg pocket site.A culture was taken and confirmed the type of infection was staphylococcus aureus.The patient was given an oral antibiotic (levaquin), and the patient underwent surgery to relocate the ipg site from the flank to the buttock.There was no report of patient harm or injury.Mainstay medical was unaware of this event and was not present during the ipg relocation surgery.The device manufacturing record was reviewed - no non-conformance was found that would have contributed to the alleged infection.
|